Annora Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANNORA PHARMA, and what generic and branded alternatives to ANNORA PHARMA drugs are available?
ANNORA PHARMA has forty-one approved drugs.
There are four tentative approvals on ANNORA PHARMA drugs.
Summary for Annora Pharma
US Patents: | 0 |
Tradenames: | 34 |
Ingredients: | 34 |
NDAs: | 41 |
Patent Litigation for Annora Pharma: | See patent lawsuits for Annora Pharma |
Drugs and US Patents for Annora Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annora Pharma | POLYETHYLENE GLYCOL 3350 | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 214990-001 | Apr 14, 2021 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Annora Pharma | DEFERASIROX | deferasirox | TABLET;ORAL | 214341-003 | May 14, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Annora Pharma | DEFERASIROX | deferasirox | TABLET;ORAL | 214341-002 | May 14, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Annora Pharma | IVABRADINE HYDROCHLORIDE | ivabradine hydrochloride | TABLET;ORAL | 213366-002 | Oct 5, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Annora Pharma | DICLOFENAC POTASSIUM | diclofenac potassium | FOR SOLUTION;ORAL | 215375-001 | Mar 4, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Annora Pharma | FAMOTIDINE | famotidine | TABLET;ORAL | 215766-002 | Nov 8, 2021 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.